Biogen Pharmachem Industries Profile
Key Indicators
- Authorised Capital ₹ 91.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 65.26 Cr
as on 16-11-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Biogen Pharmachem Industries
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531752.
The Corporate was formerly known as Wellworth Overseas Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 91.00 Cr and a paid-up capital of Rs 65.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biogen Pharmachem Industries Limited India are Khushboo Khandelwal as COMPANY SECRETARY and Niraj Vaghela as Cfo. Niraj Vaghela, Chandrakant Parmar, Narendrakumar Vaniya, and Three other members serve as directors at the Company.
- CIN/LLPIN
L51100GJ1995PLC026702
- Company No.
026702
- Stock Symbol
BSE : 531752
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Jul 1995
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Biogen Pharmachem Industries?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khushboo Khandelwal  | Company Secretary | 14-Dec-2020 | Current |
| Niraj Vaghela | CFO | 22-Nov-2021 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Niraj Vaghela | Whole-Time Director and Cfo | 18-May-2021 | Current |
| Chandrakant Parmar | Director | 22-Nov-2021 | Current |
| Narendrakumar Vaniya | Director | 22-Mar-2023 | Current |
| Komalben Chauhan | Director | 22-Mar-2023 | Current |
| Harshadkumar Rathod | Director | 22-Mar-2023 | Current |
| Chhayaben Parmar | Additional Director | 10-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Biogen Pharmachem Industries.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biogen Pharmachem Industries?
Unlock access to Biogen Pharmachem Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Suncare Traders LimitedActive 27 years 10 monthsNarendrakumar Vaniya, Harshadkumar Rathod and 1 more are mutual person
- Regis Industries LimitedActive 42 years 8 months
Chandrakant Parmar, Komalben Chauhan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biogen Pharmachem Industries?
Unlock and access historical data on people associated with Biogen Pharmachem Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogen Pharmachem Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogen Pharmachem Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
